BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9372912)

  • 1. Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation.
    Deed RW; Hara E; Atherton GT; Peters G; Norton JD
    Mol Cell Biol; 1997 Dec; 17(12):6815-21. PubMed ID: 9372912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors.
    Hara E; Hall M; Peters G
    EMBO J; 1997 Jan; 16(2):332-42. PubMed ID: 9029153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation.
    Matsumura ME; Lobe DR; McNamara CA
    J Biol Chem; 2002 Mar; 277(9):7293-7. PubMed ID: 11706002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
    Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
    Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal regulation and differential actions of the helix-loop-helix transcriptional inhibitors of differentiation (Id1, Id2, Id3, and Id4) in Sertoli cells.
    Chaudhary J; Johnson J; Kim G; Skinner MK
    Endocrinology; 2001 May; 142(5):1727-36. PubMed ID: 11316735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E-CDK2 is a regulator of p27Kip1.
    Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
    Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding.
    Harris TE; Albrecht JH; Nakanishi M; Darlington GJ
    J Biol Chem; 2001 Aug; 276(31):29200-9. PubMed ID: 11369759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupling of cell growth control and apoptosis functions of Id proteins.
    Norton JD; Atherton GT
    Mol Cell Biol; 1998 Apr; 18(4):2371-81. PubMed ID: 9528806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins.
    Lasorella A; Iavarone A; Israel MA
    Mol Cell Biol; 1996 Jun; 16(6):2570-8. PubMed ID: 8649364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase activating polypeptide anti-mitogenic signaling in cerebral cortical progenitors is regulated by p57Kip2-dependent CDK2 activity.
    Carey RG; Li B; DiCicco-Bloom E
    J Neurosci; 2002 Mar; 22(5):1583-91. PubMed ID: 11880488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
    Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
    Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
    Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
    Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.